ifosfamide has been researched along with Sjogren's Syndrome in 1 studies
Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, K | 1 |
| Haberberger, RV | 1 |
| Gordon, TP | 1 |
| Jackson, MW | 1 |
1 other study available for ifosfamide and Sjogren's Syndrome
| Article | Year |
|---|---|
Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
Topics: Acetylcholine; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Autoan | 2011 |